CACI is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 available. The stock is near resistance and has already run up sharply, while analyst targets have been trending lower and institutional selling is rising. It still has solid long-term defense/modernization exposure, but based on the current setup I would not call it a clear buy today; I would hold off and wait for a better entry rather than chase the move.
CACI is in a positive short-term trend, but the setup is extended. MACD histogram is above zero and expanding, which supports bullish momentum. However, RSI_6 is elevated at 76.954, suggesting the stock is stretched after the recent move. Price closed at 526, just above R1 at 521.636 and below R2 at 533.106, so it is pressing into resistance rather than breaking out cleanly. Converging moving averages indicate the trend is improving, but the current price is not an especially attractive entry for a patient long-term buyer.

["MACD is positive and expanding, supporting upward momentum.", "Defense and government services exposure remains a favorable long-term business theme.", "Wells Fargo recently initiated coverage with an Overweight rating and $725 price target.", "Citi said there may be buying opportunities after recent selloffs in the sector."]
["No news in the past week, so there is no fresh event-driven catalyst.", "Several analysts have cut price targets recently, including Citi and Jefferies.", "BNP Paribas initiated with a Neutral rating and $550 target.", "Hedge funds are selling, with selling up 213.89% over the last quarter.", "The stock is trading near resistance after a strong move, making the entry less attractive.", "Pattern analysis suggests downside risk over the next month."]
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot assess the most recent quarter's revenue or earnings growth directly. The only financial-related context available is analyst commentary tied to Q1 and Q3 reports, which described the quarter as solid but not enough to prevent multiple target cuts. The latest quarter season was not supplied in the data.
Analyst sentiment is mixed-to-neutral. Recent changes show a clear trend of lower price targets: BNP Paribas initiated Neutral at $550, Citi cut to $555 from $614 and kept Neutral, Jefferies cut to $550 from $645 and kept Hold, and Citi earlier cut to $614 from $721. TD Cowen remains bullish with a Buy and $625 target, and Wells Fargo is the most positive with Overweight and $725. Overall, Wall Street sees quality long-term exposure, but the near-term pros and cons view is balanced to cautious rather than aggressively bullish.